Alpha 2.0
Login Register
» Articles » PMID: 15687596

Development of Herceptin

Overview
Journal Breast Dis
Publisher Sage Publications
Specialty Gynecology & Obstetrics
Date 2005 Feb 3
PMID 15687596
Citations 7
Authors
P Carter
B M Fendly
G D Lewis
M X Sliwkowski
Affiliations
Soon will be listed here.
Citing Articles

Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr phosphorylation.

Gaviraghi M, Rabellino A, Andolfo A, Brand M, Brombin C, Bagnato P Sci Rep. 2020; 10(1):16906.

PMID: 33037285 PMC: 7547737. DOI: 10.1038/s41598-020-73835-1.

Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2 breast cancer samples.

Vasmatzis G, Wang X, Smadbeck J, Murphy S, Geiersbach K, Johnson S BMC Cancer. 2018; 18(1):738.

PMID: 30005627 PMC: 6045826. DOI: 10.1186/s12885-018-4594-0.

Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.

Lehmann A, Wixted J, Shapovalov M, Roder H, Dunbrack Jr R, Robinson M MAbs. 2015; 7(6):1058-71.

PMID: 26337947 PMC: 4966335. DOI: 10.1080/19420862.2015.1088618.

Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging.

Macdonald-Obermann J, Adak S, Landgraf R, Piwnica-Worms D, Pike L J Biol Chem. 2013; 288(42):30773-30784.

PMID: 24014028 PMC: 3798547. DOI: 10.1074/jbc.M113.489534.

Reorienting the Fab domains of trastuzumab results in potent HER2 activators.

Scheer J, Sandoval W, Elliott J, Shao L, Luis E, Lewin-Koh S PLoS One. 2013; 7(12):e51817.

PMID: 23284778 PMC: 3527469. DOI: 10.1371/journal.pone.0051817.